Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma.

Oncotarget - 1 Nov 2016

Zhou Na, Liu Congmin, Hou Helei, Zhang Chuantao, Liu Dong, Wang Guanqun, Liu Kewei, Zhu Jingjuan, Lv Hongying, Li Tianjun, Zhang Xiaochun

Abstract excerpt

Spindle cell carcinoma of the breast is a rare subtype of metaplastic carcinoma, and no effective chemotherapy special for metaplastic carcinoma exists until now. As spindle cell carcinomas of the breast are typically "Triple Negative", endocrine therapy and molecular therapy targeted to Her2 might not be favorable, resulting in poor prognosis. Apatinib is currently being tested in patients with breast or lung...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bevacizumab
Share to Breast
Share to Chemotherapy, Adjuvant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclophosphamide

Share to Epirubicin

Share to Positron Emission Tomography Computed Tomography

Share to Receptors, Vascular Endothelial Growth Factor

Share to Triple Negative Breast Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 27738308
DOI: 10.18632/oncotarget.12568
PMCID: PMC5342168

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma.PMID 27738308Read ↗

Molecular Profiling of the Metaplastic Spindle Cell Carcinoma of the Breast Reveals Potentially Targetable Biomarkers.Semantic proximity Read ↗

Successful maintenance therapy with apatinib inplatinum-resistant advanced ovarian cancer and literature review.Semantic proximity Read ↗

Effective treatment with Dabrafenib and Trametinib for a BRAF-mutated metastatic dedifferentiated malignant spindle cell neoplasm.Semantic proximity Read ↗

Genome-wide CRISPR screen identifies ESPL1 limits the response of gastric cancer cells to apatinibSemantic proximity Read ↗

Successful treatment of Afatinib plus Apatinib using for a lung adenocarcinoma patient with HER-2 V659D mutation: a rare case report.Semantic proximity Read ↗

A Novel ALK Fusion Gene (NSF-ALK) Identified in a Patient With Recurrent Spindle Cell Sarcoma Respond to Crizotinib: A Case ReportSemantic proximity Read ↗

Advanced renal pelvis carcinoma patient with an ERBB2 insertion mutation: a case report.Semantic proximity Read ↗

Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.Semantic proximity Read ↗

Could spindle cell lung carcinoma be considered and treated as sarcoma, according to its clinical course, morphology, immunophenotype and genetic finding?Semantic proximity Read ↗

Pulmonary Pleomorphic Carcinoma Harboring EGFR Mutation Successfully Treated with Osimertinib: A Case Report.Semantic proximity Read ↗

Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal CarcinomatosisSemantic proximity Read ↗

Niraparib as Maintenance Therapy in Germline ATM-mutated and Somatic BRCA2-mutated Ovarian Cancer with Brain Metastases: A Case Report and Literature ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.